Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Aug - Godrej Industries Group signs Haryana MoU for ₹20,000 crore investment, targeting 40,000 jobs by FY28.
Source: Bse
Diversified stocks · Large cap · NSE
Godrej Industries Limited is a diversified Indian conglomerate with own businesses in Chemicals, Estate Management, and Finance & Investments. It also holds significant stakes in listed subsidiaries: Godrej Consumer Products (FMCG), Godrej Properties (Real Estate), and Godrej Agrovet (Agri-business).
SMA20 -9.0% / mo · MACD +
Latest FPI flow is positive, but a second consecutive positive fortnight is still required. View sector evidence
Adjusted completed-session prices, rebased to 100
No exact NSE sector index is mapped for this company. Nifty 500 remains the broad-market comparison.
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +22.1% · PAT -27.9% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
PAT -28% YoY · Rev +22% YoY · margin expansion
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹5,448 Cr | +22.1% | -29.2% |
| EBITDA | ₹575 Cr | +44.8% | -50.7% |
| Operating margin | 11.0% | +200 bps | -400 bps |
| PAT | ₹523 Cr | -27.9% | -37.8% |
| PAT margin | 9.6% | -666 bps | -133 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 19/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 39. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 19 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Diversified — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Godrej Industries reported robust Q4 FY26 consolidated performance with Total Income up 29% YoY to ₹8,274 crore and Net Profit surging 143% YoY to ₹444 crore. Full-year FY26 Total Income grew 19% to ₹25,981 crore, with Net Profit up 26% to ₹1,241 crore.
Strong consolidated financial performance in Q4 and FY26, driven by robust growth across key subsidiaries like Godrej Properties and Godrej Consumer Products, and improved profitability in Chemicals and Agrovet. The diversified portfolio appears to be executing well.
Latest issuer-disclosed distribution across 5 reported categories.
Booking value grew 16% YoY and at a 3-year CAGR of 41% to ₹ 34,171 crore in FY26. Q4FY26 booking value was the highest ever quarterly bookings by GPL.
Home Care grew by 12%. Household Insecticides delivered strong broad-based growth. Fabric Care maintained robust double-digit growth momentum.
Q4 FY26 saw accelerated, broad-based volume growth of ~15% year-on-year across most categories, with cattle feed volumes rising sharply by 24% year-on-year.
Revenue for Q4 FY26 increased by 16%. Sales Volume grew by 9% in FY26.
GPL has added 18 new projects in FY26 with a total estimated saleable area of approximately 33.32 million sq. ft. and total estimated booking value potential of ~ ₹ 42,100 crore.
NG Star Application Lab in Ambernath-Maharashtra supports product development, application testing, and technical collaboration.
Household Insecticides, Fabric Care, Soaps, and Hair Colour continue to gain market share consistently driven by strong in-market execution.
Vegetable Oil segment mitigated higher input costs impact through improved oil extraction ratio & other operational efficiencies.
Vegetable Oil segment margin was marginally lower on account of higher input costs.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Q4 YoY comparison is crucial for understanding recent momentum and seasonal impacts, especially for consumer and agri businesses. FY26 YoY provides a full-year perspective on overall growth and profitability trends across the diversified portfolio.
Q4 FY 2026 consolidated sales grew by 11% year-on-year on the back of underlying volume growth of 6%
Home Care grew by 12%.
Personal Care grew by 3%
Revenue for Q4 FY26 increased by 16%
GPL has added 18 new projects in FY26 with a total estimated saleable area of approximately 33.32 million sq. ft. and total estimated booking value potential of ~ ₹ 42,100 crore.
Skin Cleansing continues to upgrade to premium formats. Soaps and Hair Colour continue to win competitively and gain market share.
The NG Star Application Lab supports product development, application testing, and technical collaboration to translate chemistry into real world performance.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| GPL Booking Value | ₹ 34,171 crore in FY26 | Sustained growth in booking value and successful monetization of new project additions. |
| GCPL Volume Growth | Underlying volume growth of 6% in Q4 FY26 | Continued underlying volume growth across key categories, especially Home Care and Personal Care. |
| GAVL Animal Nutrition Volume | Volume growth of ~15% year-on-year in Q4 FY26 | Maintenance of accelerated volume growth in Animal Nutrition, particularly cattle feed. |
| Chemicals PBIT Margin | 3.6% in Q4 FY26 (vs. 7.8% in Q4 FY25 and 7.4% in FY26) | Improvement in Chemicals PBIT margin, which saw a significant sequential decline in Q4 FY26. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 10th percentile of the scored universe and 17th percentile within Diversified. Main check: balance sheet trust is weak at 8/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Diversified: 17th pctile, median 61 · Large: 5th pctile, median 73
84 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse